Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases.
about
MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkersEpithelioid angiosarcoma arising in schwannoma of the kidney: report of the first case and review of the literature.Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on TrabectedinOccupational cancer in Britain. Remaining cancer sites: brain, bone, soft tissue sarcoma and thyroidSoft tissue tumors of the anorectum: rare, complex and misunderstoodIncidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testingIncidence, and gender, age and ethnic distribution of sarcomas in the republic of suriname from 1980 to 2008Clinically Relevant Molecular Subtypes in LeiomyosarcomaMusculoskeletal sonopathology and ultrasound-guided regional anesthesia.Results of a Qualitative Study to Develop a Patient Reported Outcome Measure for Patients with 4 Subtypes of Soft Tissue Sarcoma.A European project on incidence, treatment, and outcome of sarcoma.Relevance of MRI in prediction of malignancy of musculoskeletal system--a prospective evaluation.Outcomes of first-line chemotherapy in patients with advanced or metastatic leiomyosarcoma of uterine and non-uterine originPrognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Epithelioid angiosarcoma arising in a uterine leiomyoma with associated elevated CA-125: A case report.The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcomaSystemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and EribulinGene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.Prevalence of malignant soft tissue tumors in extremities: an epidemiological study in syria.Orthopaedic case of the month: A 30-year-old woman with a painful forearm mass.10 rare tumors that warrant a genetics referral.Diagnosis and treatment of sarcoma of the uterus. A review.Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.Sarcomas in hereditary retinoblastomaProgressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review.Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database.Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma.Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report.Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.Physeal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGEntropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas.Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO).Classification, molecular characterization, and the significance of pten alteration in leiomyosarcoma.Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
P2860
Q27006159-E3E88A74-C0E6-4BA2-A3FB-D946D298F0A3Q28073601-910FD1D6-028C-41A0-A070-C158D5557A35Q28087771-F3E87912-DBC0-4D6E-B6D5-8C058AA467F0Q28385734-5AA88ED9-E2F1-4DC9-9E7E-46AE4790C9FEQ28393971-33B7E1A7-15C0-4EAF-942E-ABC7226DE6DFQ28741842-1ABB5E6A-7E9F-494B-B1E8-E2AB0FFD545AQ29353691-2C0D8741-7C05-4B1D-A363-0482C205063CQ30300155-F91D456B-A761-4C16-830A-20DD786DF990Q30428527-C4DD8836-49CD-4AF2-8547-2709699289FBQ30853762-D6E88044-D920-4256-A322-BAF34BCBF5CCQ30980513-A7C470F9-A37E-4820-8867-C8445BD608FAQ33509189-C06AD7ED-11EA-4C6C-9449-31CF95657160Q33523297-B4F5289E-29DE-4453-8DEE-692C70D19D0AQ33563921-3B3BF4B8-28F7-4BFB-8C30-B28D464F17F6Q33647672-4297F63B-735D-4BDB-8C63-62111DEF4124Q33679851-826AB508-3E2B-42BE-A837-A53CBD555CE2Q33697112-8ABF4F48-8FFF-4922-9362-3D8BFD0DE052Q33732473-5F155F99-8F6B-4F6C-BACB-55800133A655Q33890846-50FB9F1D-AFAB-4C42-908B-38614BB800FCQ33910538-10D84610-FE91-4CCE-A314-44CAC3617399Q34118623-DF427C32-5983-4C86-8C9F-06AD7B89B4BDQ34164561-40F1364F-D0BF-480E-85B0-59DD59978040Q34325954-B203351B-0678-40B2-B139-0E6380751639Q34336818-A1EFFF31-EDCF-4A7B-ADC2-993A7DAECEA7Q34402363-6A7C06BA-766D-48FA-8466-4CA7E77BE66AQ34433701-26DC5F43-CF42-4073-B8A5-51E13DA5E429Q34588863-00D80013-D534-4B21-8EE3-03868FF74371Q34613152-86445773-F2EB-48C6-A33F-6883088BBA04Q34631244-96A86189-A8CA-410E-8E00-69FAC50C23EBQ34633273-EB5BD534-498B-45E6-8EEF-89BCB5F1CBFEQ34663373-EB65AB00-38A3-4D66-AC5C-8BCA1375F2A4Q34870799-CA81A1C8-1EF2-43DC-B52F-BB20ADC68C19Q34929490-84C2DD42-AA78-4C6A-9FE5-B0EE4AFFE62CQ35060432-681CE2C5-AAB0-48F8-A5F7-6D125816EBD5Q35180929-CADB07C4-89DC-49C6-A59C-7042706B20D7Q35538338-453A2575-A9A5-419F-A04A-434CD564E7ADQ35663503-4F305A13-11D0-4B6D-965B-A48A5AB12D5DQ35788748-94E6B016-62F6-4416-978C-D9A204DF95B2Q35927459-402E58D7-25C8-4E4D-AFF9-F3CA00C6FC8EQ36012079-95D8FB9D-92FD-4B88-85E0-263577C2C8D9
P2860
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@en
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@nl
type
label
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@en
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@nl
prefLabel
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@en
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@nl
P2093
P2860
P356
P1476
Incidence patterns of soft tis ...... : An analysis of 26,758 cases.
@en
P2093
Christopher D M Fletcher
Hongyu Julian Wu
Jorge R Toro
Kangmin Zhu
Lois B Travis
P2860
P304
P356
10.1002/IJC.22239
P577
2006-12-01T00:00:00Z